In the news

How does losing weight with medication work? Video on losing weight with Semaglutide & Tirzateptide
November 7, 2022

Watch the video about losing weight with medication. This video clip from Weightloss wednesdays is about losing weight with Semaglutide & Tirzateptide, with user experiences about weight loss: “It’s easy. It’s painless, and it was a miracle. In three weeks I lost 18 pounds, and after three months I had lost 38 pounds…”

Pioneering obesity drug helps teens lose weight, study shows
November 5, 2022

A medicine called semaglutide, approved for overweight adults, also helps young people lose pounds and have healthier hearts, according to a new study published in the New England Journal of Medicine.
Read more…

Does intermittent fasting affect female hormones?
November 5, 2022

“We saw reductions in body weight, fat mass, insulin levels and insulin resistance.” – Dr. Krista Varady, lead author and professor of nutrition at the University of Illinois, Chicago.
Read more…

I want to keep up to date with the latest news.

Subscribe directly to the newsletter

    Lilly's new diabetes medicine has doubled sales expectations. It can also be used against obesity.
    November 2, 2022

    Sales of Mounjaro, Eli Lilly’s new type 2 diabetes therapy that can also be used in obesity treatments, far exceeded Wall Street expectations in the third quarter of the year.
    Read more…

    Many turn to diabetes drug Ozempic to lose weight. Is it safe?
    October 27, 2022

    It’s become a sensation on social media, with the topic “Ozempic” garnering over 300 million views on TikTok. Many people who don’t have diabetes are using it off-label — the practice of taking an approved drug for unapproved use — and crediting it for their weight-loss success.
    Read more…

    Semaglutide's biggest fan: Elon Musk
    October 24, 2022

    Last week an interview with American ICU doctor Michael Daignault about Elon Musk and Semaglutide was released. Elysee freely translated it into Dutch and did not want to withhold the article from you.
    Read the article…

    Amgen takes on Novo and Lilly in treating obesity.
    October 10, 2022

    In a report, a Morgan Stanley analyst said that Amgen (AMGN) could have a drug worth millions of dollars on its hands with AMG133. The drug blocks a hormone and a protein involved in blood sugar levels.
    Read more…

    'Game changer' painless injections to lose pounds
    October 10, 2022

    Watch the video on experiences with ‘game changing’ weight loss medication:

    “It’s simple. It’s painless, and it was a miracle. In three weeks I lost 18 pounds, and by three months, I had lost 38 pounds…”

    People lost more than 20 kilos with new FDA-approved pill medication
    October 7, 2022

    Obese people treated with a weekly dose of Tirzepatide, a new GIP/GLP-1 receptor agonist sold under the brand name Mounjaro, lost an average of 20 pounds, according to the results of a new study published in New England Journal of Medicine.
    Read more…

    Long-term success may depend on how well a diet plan works in the short term.
    September 19, 2022

    A new study of people with type 2 diabetes in a weight-loss program found that if they did not lose 0.5% of their body weight within the first 4 weeks, their likelihood of long-term success was lower and a change of plan was best.
    Read more…

    Scientists redefine obesity with discovery of two major subtypes
    September 14, 2022

    A team led by scientists at the Van Andel Institute has identified two different types of obesity with physiological and molecular differences that may have lifelong implications for health, disease and response to medication.
    Read more…

    Game-changing obesity drug halves risk of type 2 diabetes
    September 14, 2022

    The risk of type 2 diabetes (T2D) is more than halved by weekly injections of the new obesity drug semaglutide, according to new research presented at the annual meeting of the European Association for the Study of Diabetes (EASD) in Stockholm, Sweden.
    Read more…

    Myths about belly fat you should stop believing
    September 14, 2022

    If you have fat in your belly, you may be looking for ways to get rid of it. The Cleveland Clinic explains that extra fat in your belly can increase your risk of diabetes, fatty liver, heart disease, high cholesterol, some types of cancer and polycystic ovarian syndrome.
    Read more…

    Eli Lilly prepares to enter pharmaceutical obesity market
    September 13, 2022

    Mounjaro, Eli Lilly’s new injectable drug for type 2 diabetes, may be marketed under two names – one for diabetics, the other for obese patients.
    Read more…

    This diabetes medication is prescribed for weight loss. Now there is a shortage
    September 9, 2022

    A diabetes drug that increases insulin sensitivity and suppresses appetite, often leading to weight loss, has recently faced shortages coinciding with the drug’s exploding popularity on TikTok as a kind of miracle drug for weight loss.
    Read more…

    Sugar disrupts microbiome and worsens protection against obesity and diabetes
    August 30, 2022

    A study found that sugar in food alters the gut microbiome, causing symptoms leading to metabolic diseases, pre-diabetes and weight gain.
    Read more…

    Novo Nordisk makes all doses of the weight-loss medicines available in the U.S. by the end of 2022
    August 4, 2022

    With production of the Wegovy weight-loss drug finally underway, Novo Nordisk plans to make all dosage strengths available in the US by the end of the year.
    Read more…

    The effect of once-weekly use of GLP-1 agonists against obesity
    July 21, 2022

    Watch the video on the efficacy and safety of tirzepatide, a new glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 receptor agonist, in obese people.

    Change in reimbursement of Saxenda (liraglutide) and GLP-1 agonists (semaglutide)
    July 7, 2022

    The medicineliraglutide (Saxenda®) can be reimbursed from the basic package for the treatment of a small group of people with severe obesity. From July 1, 2022, the conditions for this have changed.
    Read more…